anmelden
FTSE All-Share
5.526,27
PKT
-75,33
PKT
-1,34
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.12.11 | Barclays neutral | Exane-BNP Paribas SA | |
| 21.12.11 | Lloyds Banking Group underperform | Exane-BNP Paribas SA | |
| 21.12.11 | HSBC outperform | Exane-BNP Paribas SA | |
| 21.12.11 | AstraZeneca reduce | Nomura | |
| 21.12.11 | Burberry hold | Société Générale Group S.A. (SG) | |
| 20.12.11 | BAT buy | Société Générale Group S.A. (SG) | |
| 19.12.11 | Shell (ex Royal Dutch Shell) kaufen | Die Actien-Börse | |
| 19.12.11 | Glencore underperform | Exane-BNP Paribas SA | |
| 16.12.11 | Antofagasta neutral | J.P. Morgan Cazenove | |
| 16.12.11 | Antofagasta neutral | UBS AG | |
| 16.12.11 | Antofagasta neutral | UBS AG | |
| 16.12.11 | Unilever neutral | UBS AG | |
| 16.12.11 | Antofagasta sector perform | Scotia Capital Markets | |
| 16.12.11 | AstraZeneca halten | Independent Research GmbH | |
| 16.12.11 | Antofagasta hold | Société Générale Group S.A. (SG) | |
| 16.12.11 | Vodafone Group outperform | Credit Suisse Group | |
| 15.12.11 | AstraZeneca hold | Deutsche Bank AG | |
| 15.12.11 | London Stock Exchange (LSE) sell | Goldman Sachs Group Inc. | |
| 15.12.11 | GSK hold | Deutsche Bank AG | |
| 14.12.11 | Prudential overweight | Barclays Capital | |
| 14.12.11 | Rio Tinto overweight | J.P. Morgan Cazenove | |
| 14.12.11 | Shell (ex Royal Dutch Shell) neutral | Citigroup Corp. | |
| 14.12.11 | Imperial Brands buy | Société Générale Group S.A. (SG) | |
| 14.12.11 | BP neutral | Citigroup Corp. | |
| 13.12.11 | BP outperform | Oppenheimer & Co. Inc. | |
| 13.12.11 | London Stock Exchange (LSE) neutral | UBS AG | |
| 13.12.11 | AstraZeneca underperform | Credit Suisse Group | |
| 13.12.11 | Vodafone Group sell | Société Générale Group S.A. (SG) | |
| 13.12.11 | BP neutral | Goldman Sachs Group Inc. | |
| 12.12.11 | Glencore buy | UBS AG | |
| 12.12.11 | Glencore buy | UBS AG | |
| 12.12.11 | Vodafone Group overweight | Morgan Stanley | |
| 09.12.11 | Vodafone Group buy | Banc of America Securities-Merrill Lynch | |
| 09.12.11 | Anglo American overweight | J.P. Morgan Cazenove | |
| 09.12.11 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 09.12.11 | Standard Chartered buy | Nomura | |
| 09.12.11 | Vodafone Group overweight | Barclays Capital | |
| 08.12.11 | Sky buy | UBS AG | |
| 08.12.11 | AstraZeneca neutral | Citigroup Corp. | |
| 08.12.11 | Anglo American buy | UBS AG |